These data suggest that systemic serum cytokine levels from patients with CF are comparable to patients diagnosed with SAID and can be characterised by release of proinflammatory IL-1-type cytokine family members (IL-1β and IL-18), associated with NLRP3 inflammasome activation. This evidence concerns the gene NLRP3 and cystic fibrosis.